VBIO ▲ +20.1% - Valion Bio, Inc.
$VBIO - Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
30-SEP-2026 07:45 AM ET
Share this post
More filings for $VBIO
VBIO ▲ +8.4% - Valion Bio, Inc.Sep 23, 2026VBIO ▼ -1.7% - Valion Bio, Inc.Sep 22, 2026VBIO ▼ -5.6% - Valion Bio, Inc.Sep 1, 2026VBIO - Valion Bio, Inc. - SEC Filing Update (27-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 28, 2026VBIO ▼ -18.8% - Valion Bio, Inc.Aug 27, 2026VBIO - Valion Bio, Inc. - SEC Filing Update (24-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 25, 2026
View full $VBIO filing history →💬 Comments
Loading comments…
Leave a comment